azoxymethane has been researched along with balsalazide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, LK; Kim, YS; MacGregor, DJ; Sleisenger, MH | 1 |
| Byeon, JS; Cho, EA; Chung, EJ; Do, EJ; Hwang, SW; Kim, JH; Kim, SY; Lee, HJ; Myung, SJ; Park, S; Park, SH; Ryu, YM; Yang, DH; Yang, SK; Ye, BD | 1 |
2 other study(ies) available for azoxymethane and balsalazide
| Article | Year |
|---|---|
Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Anticarcinogenic Agents; Azoxymethane; Cell Division; Colonic Neoplasms; Genes, APC; Humans; Indomethacin; Intestinal Mucosa; Intestinal Neoplasms; Mesalamine; Mice; Mice, Mutant Strains; Phenylhydrazines; Prodrugs; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2000 |
Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Azoxymethane; bcl-2-Associated X Protein; Cell Transformation, Neoplastic; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Agents; Inflammation Mediators; Interleukin-6; Macrophages; Male; Mesalamine; Mice, Inbred C57BL; Phenylhydrazines; Phosphorylation; Probiotics; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Time Factors | 2016 |